Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Visual kinesthesia and locomotion in Parkinson's disease.

Identifieur interne : 001006 ( Ncbi/Merge ); précédent : 001005; suivant : 001007

Visual kinesthesia and locomotion in Parkinson's disease.

Auteurs : Martin Schubert [Allemagne] ; Thomas Prokop ; Frank Brocke ; Wiltrud Berger

Source :

RBID : pubmed:15390031

English descriptors

Abstract

We investigated predominance of visual control in Parkinson's disease (PD) gait regulation and whether visual kinesthesia has systematic effects on gait parameters. Effects of artificial optic flow were studied on walking velocity (WV), stride length (SL), and stride frequency (SF) during treadmill walking in PD patients and young and elderly adults. The independent variable was relative optic flow (rOF), ranging from -1 times (forward flow, i.e., in walking direction) to 3 times WV (backward flow, natural direction). All walkers were influenced similarly by rOF, inducing systematic changes of WV. Backward flow caused a decrease and forward flow an increase of WV. Without effect of rOF, PD patients on average walked at 0.89 meters per second compared to 1.31 meters per second in the age-matched healthy group. The rOF-induced mean changes of WV in all PD patients amounted to 0.45 meters per second (50.4%), with 45.1% due to changes in SL and 5.3% to SF. In the age-matched, rOF-induced WV changes reached 0.18 meters per second (13.8%), with 10.8% due to SL and 3.2% to SF. Thus, compared to the results of the age-matched group, effects of rOF in PD patients were stronger, which increased WV to a normal level by normalization of SL. Contrary to the healthy subjects, no attenuation of optic flow effects over time was observed in the PD patients. Predominance of visual control in PD gait is suggested due to deficits in proprioception compensated by visual kinesthesia, causing exaggerated reaction to visual feedback. The results extend beyond earlier findings, generally stating improvement of PD gait by presence of visual feedback but show systematic effects on gait parameters due to reweighting of visual kinesthesia.

DOI: 10.1002/mds.20281
PubMed: 15390031

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:15390031

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Visual kinesthesia and locomotion in Parkinson's disease.</title>
<author>
<name sortKey="Schubert, Martin" sort="Schubert, Martin" uniqKey="Schubert M" first="Martin" last="Schubert">Martin Schubert</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurology, University Hospital of Freiburg, Germany. schubert@nz11.ukl.uni-freiburg.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University Hospital of Freiburg</wicri:regionArea>
<wicri:noRegion>University Hospital of Freiburg</wicri:noRegion>
<wicri:noRegion>University Hospital of Freiburg</wicri:noRegion>
<wicri:noRegion>University Hospital of Freiburg</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Prokop, Thomas" sort="Prokop, Thomas" uniqKey="Prokop T" first="Thomas" last="Prokop">Thomas Prokop</name>
</author>
<author>
<name sortKey="Brocke, Frank" sort="Brocke, Frank" uniqKey="Brocke F" first="Frank" last="Brocke">Frank Brocke</name>
</author>
<author>
<name sortKey="Berger, Wiltrud" sort="Berger, Wiltrud" uniqKey="Berger W" first="Wiltrud" last="Berger">Wiltrud Berger</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15390031</idno>
<idno type="pmid">15390031</idno>
<idno type="doi">10.1002/mds.20281</idno>
<idno type="wicri:Area/PubMed/Corpus">003282</idno>
<idno type="wicri:Area/PubMed/Curation">003282</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F10</idno>
<idno type="wicri:Area/Ncbi/Merge">001006</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Visual kinesthesia and locomotion in Parkinson's disease.</title>
<author>
<name sortKey="Schubert, Martin" sort="Schubert, Martin" uniqKey="Schubert M" first="Martin" last="Schubert">Martin Schubert</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurology, University Hospital of Freiburg, Germany. schubert@nz11.ukl.uni-freiburg.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University Hospital of Freiburg</wicri:regionArea>
<wicri:noRegion>University Hospital of Freiburg</wicri:noRegion>
<wicri:noRegion>University Hospital of Freiburg</wicri:noRegion>
<wicri:noRegion>University Hospital of Freiburg</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Prokop, Thomas" sort="Prokop, Thomas" uniqKey="Prokop T" first="Thomas" last="Prokop">Thomas Prokop</name>
</author>
<author>
<name sortKey="Brocke, Frank" sort="Brocke, Frank" uniqKey="Brocke F" first="Frank" last="Brocke">Frank Brocke</name>
</author>
<author>
<name sortKey="Berger, Wiltrud" sort="Berger, Wiltrud" uniqKey="Berger W" first="Wiltrud" last="Berger">Wiltrud Berger</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adaptation, Psychological</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Exercise Test (methods)</term>
<term>Gait (physiology)</term>
<term>Humans</term>
<term>Kinesthesis (physiology)</term>
<term>Locomotion (physiology)</term>
<term>Middle Aged</term>
<term>Motion Perception (physiology)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Psychomotor Performance (physiology)</term>
<term>Reference Values</term>
<term>Time Factors</term>
<term>Walking (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Exercise Test</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Gait</term>
<term>Kinesthesis</term>
<term>Locomotion</term>
<term>Motion Perception</term>
<term>Psychomotor Performance</term>
<term>Walking</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adaptation, Psychological</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Reference Values</term>
<term>Time Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We investigated predominance of visual control in Parkinson's disease (PD) gait regulation and whether visual kinesthesia has systematic effects on gait parameters. Effects of artificial optic flow were studied on walking velocity (WV), stride length (SL), and stride frequency (SF) during treadmill walking in PD patients and young and elderly adults. The independent variable was relative optic flow (rOF), ranging from -1 times (forward flow, i.e., in walking direction) to 3 times WV (backward flow, natural direction). All walkers were influenced similarly by rOF, inducing systematic changes of WV. Backward flow caused a decrease and forward flow an increase of WV. Without effect of rOF, PD patients on average walked at 0.89 meters per second compared to 1.31 meters per second in the age-matched healthy group. The rOF-induced mean changes of WV in all PD patients amounted to 0.45 meters per second (50.4%), with 45.1% due to changes in SL and 5.3% to SF. In the age-matched, rOF-induced WV changes reached 0.18 meters per second (13.8%), with 10.8% due to SL and 3.2% to SF. Thus, compared to the results of the age-matched group, effects of rOF in PD patients were stronger, which increased WV to a normal level by normalization of SL. Contrary to the healthy subjects, no attenuation of optic flow effects over time was observed in the PD patients. Predominance of visual control in PD gait is suggested due to deficits in proprioception compensated by visual kinesthesia, causing exaggerated reaction to visual feedback. The results extend beyond earlier findings, generally stating improvement of PD gait by presence of visual feedback but show systematic effects on gait parameters due to reweighting of visual kinesthesia.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">15390031</PMID>
<DateCreated>
<Year>2005</Year>
<Month>02</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2005</Year>
<Month>04</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>20</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2005</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Visual kinesthesia and locomotion in Parkinson's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>141-50</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We investigated predominance of visual control in Parkinson's disease (PD) gait regulation and whether visual kinesthesia has systematic effects on gait parameters. Effects of artificial optic flow were studied on walking velocity (WV), stride length (SL), and stride frequency (SF) during treadmill walking in PD patients and young and elderly adults. The independent variable was relative optic flow (rOF), ranging from -1 times (forward flow, i.e., in walking direction) to 3 times WV (backward flow, natural direction). All walkers were influenced similarly by rOF, inducing systematic changes of WV. Backward flow caused a decrease and forward flow an increase of WV. Without effect of rOF, PD patients on average walked at 0.89 meters per second compared to 1.31 meters per second in the age-matched healthy group. The rOF-induced mean changes of WV in all PD patients amounted to 0.45 meters per second (50.4%), with 45.1% due to changes in SL and 5.3% to SF. In the age-matched, rOF-induced WV changes reached 0.18 meters per second (13.8%), with 10.8% due to SL and 3.2% to SF. Thus, compared to the results of the age-matched group, effects of rOF in PD patients were stronger, which increased WV to a normal level by normalization of SL. Contrary to the healthy subjects, no attenuation of optic flow effects over time was observed in the PD patients. Predominance of visual control in PD gait is suggested due to deficits in proprioception compensated by visual kinesthesia, causing exaggerated reaction to visual feedback. The results extend beyond earlier findings, generally stating improvement of PD gait by presence of visual feedback but show systematic effects on gait parameters due to reweighting of visual kinesthesia.</AbstractText>
<CopyrightInformation>Copyright 2004 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Schubert</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, University Hospital of Freiburg, Germany. schubert@nz11.ukl.uni-freiburg.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prokop</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brocke</LastName>
<ForeName>Frank</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Berger</LastName>
<ForeName>Wiltrud</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000223">Adaptation, Psychological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000704">Analysis of Variance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005080">Exercise Test</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005684">Gait</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007699">Kinesthesis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008124">Locomotion</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009039">Motion Perception</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011597">Psychomotor Performance</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012016">Reference Values</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016138">Walking</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2004</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2005</Year>
<Month>4</Month>
<Day>26</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2004</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">15390031</ArticleId>
<ArticleId IdType="doi">10.1002/mds.20281</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Berger, Wiltrud" sort="Berger, Wiltrud" uniqKey="Berger W" first="Wiltrud" last="Berger">Wiltrud Berger</name>
<name sortKey="Brocke, Frank" sort="Brocke, Frank" uniqKey="Brocke F" first="Frank" last="Brocke">Frank Brocke</name>
<name sortKey="Prokop, Thomas" sort="Prokop, Thomas" uniqKey="Prokop T" first="Thomas" last="Prokop">Thomas Prokop</name>
</noCountry>
<country name="Allemagne">
<noRegion>
<name sortKey="Schubert, Martin" sort="Schubert, Martin" uniqKey="Schubert M" first="Martin" last="Schubert">Martin Schubert</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001006 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001006 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:15390031
   |texte=   Visual kinesthesia and locomotion in Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:15390031" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024